Physician profile
Carine E Hamo
NPI 1023351541
$904.90
in general payments reported to CMS, 2019-2025
11 companies · $21.33 in 2025
The $21.33 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.25 · 2022: $77.13 · 2023: $520 · 2024: $246 · 2025: $21.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $341.22 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $161.90 | 2023-2024 | |
| Daiichi Sankyo INC. | $111.82 | 2022-2024 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.40 | 2021-2023 | Jardiance |
| Pfizer INC. | $43.10 | 2024-2025 | |
| Ancora Heart, INC. | $39.27 | 2024 | Accucinch |
| Merck Sharp & Dohme LLC | $36.11 | 2021-2023 | |
| Alnylam Pharmaceuticals INC. | $33.74 | 2024 | Onpattro |
| Novo Nordisk INC | $21.35 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.64 | 2023 | |
| Janssen Pharmaceuticals, INC | $15.35 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carine Hamo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.